Treatment protocol on stasis edema in poorly mobile nursing home patients

Benigni, J. P.; Uhl, Jean-François; Balet, Florence; Chahim, M.

doi:10.23736/s0392-9590.18.04025-7

Cited by 11 publications

(8 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…90 The potentials of ACW in edema management have been recently pointed out in the 2018 Benigni investigation reporting the superiority of this compression option in lower limb volume reduction, compared to short stretch bandage. 99 The effectiveness of ACW in edema management compared to the multilayers compression bandages was reported this year also at the upper limb level. 100 IPC has demonstrated its effectiveness in lower limb volume reduction too 101 and recently it also demonstrated its potential use in preventing minor amputations for arterial disease, with a significant improvement in rest pain and amputation-free survival.…”

Section: Significant New Data Related To the Meeting Discussionmentioning

confidence: 97%

Section: Bandaging Adjustable Compression Wraps Intermittent Pnementioning

confidence: 97%

See 1 more Smart Citation

Global guidelines trends and controversies in lower limb venous and lymphatic disease

et al. 2019

View full text Add to dashboard Cite

Guidelines are fundamental in addressing everyday clinical indications and in reporting the current evidence-based data of related scientific investigations. At the same time, a spatial and temporal issue can limit their value. Indeed, variability in the recommendations can be found both among the same nation different scientific societies and among different nations/continents. On the other side, Garcia already published in 2014 data showing how, after three years in average, one out of five recommendations gets outdated (Martinez Garcia LM, Sanabria AJ, Garcia Alvarez E, et al. The validity of recommendations from clinical guidelines: a survival analysis. CMAJ 2014;186(16):1211–1219). The present document reports a narrative literature revision on the major international recommendations in lower limb venous and lymphatic disease management, focusing on the different countries’ guidelines, trends and controversies from all the continents, while identifying new evidence-based data potentially influencing future guidelines. World renowned experts’ opinions are also provided. The document has been written following the recorded round tables scientific discussions held at the vWINter international meeting (22–26 January 2019; Cortina d’Ampezzo, Italy) and the pre- and post-meeting literature search performed by the leading experts.

show abstract

Section: Significant New Data Related To the Meeting Discussionmentioning

confidence: 97%

Section: Bandaging Adjustable Compression Wraps Intermittent Pnementioning

confidence: 97%

Global guidelines trends and controversies in lower limb venous and lymphatic disease

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Sclerotherapy has evolved and improved over several years . However, there is still a wide variety of treatments for reticular veins, and no consensus has yet been reached .…”

Section: Introductionmentioning

confidence: 99%

Sclerotherapy for Reticular Veins in the Lower Limbs

et al. 2017

View full text Add to dashboard Cite

IMPORTANCE Reticular veins are subdermal veins located in the lower limbs and are mainly associated with aesthetic complaints. Although sclerotherapy is the treatment of choice for reticular veins in the lower limbs, no consensus has been reached regarding to the optimal sclerosant.OBJECTIVE To compare the efficacy and safety of 2 sclerosants used to treat reticular veins: 0.2% polidocanol diluted in 70% hypertonic glucose (HG) (group 1) vs 75% HG alone (group 2). DESIGN, SETTING, AND PARTICIPANTS Prospective, randomized, triple-blind, controlled, parallel-group clinical trial with patients randomly assigned in a 1:1 ratio between the 2 treatment groups from March through December 2014, with 2 months' follow-up. The study was conducted in a single academic medical center. Eligible participants were all women, aged 18 to 69 years, who had at least 1 reticular vein with a minimum length of 10 cm in 1 of their lower limbs. INTERVENTIONSThe patients underwent sclerotherapy in a single intervention with either 0.2% polidocanol plus 70% HG or 75% HG alone to eliminate reticular veins. MAIN OUTCOMES AND MEASURESThe primary efficacy end point was the disappearance of the reticular veins within 60 days after treatment with sclerotherapy. The reticular veins were measured on images obtained before treatment and after treatment using ImageJ software. Safety outcomes were analyzed immediately after treatment and 7 days and 60 days after treatment and included serious adverse events (eg, deep vein thrombosis and systemic complications) and minor adverse events (eg, pigmentation, edema, telangiectatic matting, and hematomas).RESULTS Ninety-three women completed the study, median (interquartile range) age 43.0 (24.0-61.0) years for group 1 and 41.0 (27.0-62.0) years for group 2. Sclerotherapy with 0.2% polidocanol plus 70% HG was significantly more effective than with 75% HG alone in eliminating reticular veins from the treated area (95.17% vs 85.40%; P < .001). No serious adverse events occurred in either group. Pigmentation was the most common minor adverse event, with a 3.53% treated-vein pigmentation length for group 1 and 7.09% for group 2, with no significant difference between the groups (P = .09).CONCLUSIONS AND RELEVANCE Sclerotherapy with 0.2% polidocanol diluted in 70% HG was superior to 75% HG alone in sclerosing reticular veins, with no statistical difference for complications. Pigmentation occurred in both groups, with no statistical difference between them. No serious adverse events occurred in either group. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT02054325

show abstract

“…La présence d'oedème de stase est une situation fréquente, notamment chez des patients âgés en maison de retraite ou chez des sujets sains travaillant debout, et pourrait contribuer à la symptomatologie [14]. La compression a pour effet un drainage des excès de liquide interstitiel, cependant l'apparition des symptômes et l'augmentation de volume ne sembleraient pas corrélées [15]. Danzinger a émis l'hypothèse d'une stimulation des fibres nerveuses de type C présentes dans la paroi des veines par l'intermédiaire de la libération de médiateurs inflammatoires contenus dans les leucocytes pour expliquer les douleurs veineuses [16].…”

Section: Compression Et Physiopathologie De La Douleur Veineuseunclassified

Venous symptoms and chronic venous disorders. Place of medical compression

Benigni¹

2018

Sang Thrombose Vaisseaux

Self Cite

View full text Add to dashboard Cite

La corrélation entre symptômes veineux et la présence de télangiectasies et/ou de veines réticulaires est l'un des sujets les plus controversés de la maladie veineuse chronique. Comme les symptômes peuvent ne pas être spécifiques d'une maladie veineuse chronique, il est important de pouvoir différencier les symptômes veineux des symptômes liés à d'autres causes. Certaines données suggèrent que le risque de développer des symptômes veineux est accru chez les femmes, au cours du vieillissement et de l'obésité. Le traitement des symptômes dans les formes débutantes de la maladie repose principalement sur la compression élastique, la correction des troubles statiques du pied, l'activité physique, la réduction du poids et secondairement sur les médicaments veinotoniques, voire la sclérothérapie. L'efficacité et le mode d'action de la compression médicale sont discutés dans cet article. Mots clés : maladie veineuse chronique, symptômes veineux, bas de compression médicale Abstract Venous symptoms and chronic venous disorders. Place of medical compressionThe correlation between venous symptoms and the presence of telangiectasias and/or reticular veins is one of the most controversial topics in chronic venous disorders. As symptoms may be non-specific of chronic venous disease, it is important to differentiate venous symptoms from symptoms of other causes. Some data suggest that the risk to develop venous symptoms is increased in women, advanced age and obesity. Treatment of the symptoms is mainly based on elastic compression, correction of foot static disorders, physical advice, reduction of body weight and secondarily on venoactive drugs and sclerotherapy. The efficacy and mode of action of medical compression is discussed in this article.

show abstract

Treatment protocol on stasis edema in poorly mobile nursing home patients

Cited by 11 publications

References 5 publications

Global guidelines trends and controversies in lower limb venous and lymphatic disease

Global guidelines trends and controversies in lower limb venous and lymphatic disease

Sclerotherapy for Reticular Veins in the Lower Limbs

Venous symptoms and chronic venous disorders. Place of medical compression

Contact Info

Product

Resources

About